Nixon et al. showed that HPCs were susceptible to HIV-1 infection in vitro and in vivo in humanized mice and concluded that direct infection of intermediate CD34+CD38+ HPCs by HIV-1 adversely affected their hematopoietic potential and correlated with the observed pancytopenia in HIV-1 infected patients [13]. The gene discussed is CD38; the disease is Pancytopenia.